Posted by AGORACOM-JC
at 11:56 AM on Thursday, June 11th, 2020
Why Imagine AR?
(IP:CSE) (IPNFF:OTCQB)
ImagineAR Has Already Started Commercializing Its Augmented Reality Platform
Clients Include:
NBA Sacramento Kings
Mall of America
AT&T Shape
Basketball Hall Of Fame
Milwaukee AutoShow
Microsoft Authorized Co-Sell Partner
Closed Major Financing In Q1 2020
Enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience
ImagineAR is now well positioned to further commercialize and capitalize on massive demand for Augmented Reality
Signed five year $300,000USD licensing agreement with SlapItOn to provide Augmented Reality for athletes and celebrities to engage fans
Announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for Casinos
Announced partnership with North Highland, a top ranked global consulting firm with over 5,000 consultants and 70 offices around the world
North Highland was ranked on the Forbes 2020 America’s Best Management Consulting Firms list, placing in seven categories, including one of only 31 firms ranked for Internet, Media and Entertainment.
Tags: AR, augmented reality, CSE, small cap, stocks, tsx, tsx-v Posted in Imagine AR | Comments Off on VIDEO: ImagineAR $IP.ca #AR, “Sports 2.0” & TikTok – NEXT SUPER STOCK Livestream 6/10/20 $SEV.ca $VST.ca $YDX.ca $NTAR.ca
Posted by AGORACOM
at 9:52 AM on Thursday, June 11th, 2020
SPONSOR: Mota Ventures Corp is an established natural health products company focused in the CBD and psychedelic medicine sectors. Through their powerful eCommerce business, Mota is a leading direct-to-consumer provider of a wide range of natural health products throughout the United States and Europe. Click Here for More Info
In a new study, Johns Hopkins Medicine researchers analyzed the brain scans of people after they took psilocybin, the active compound in psychedelic (magic) mushrooms, to see what happens in the brain when people are on psychedelics.
The team focused on a part of the brain known as the claustrum, taken from the Latin word for “hidden or shut away.†The claustrum is an extremely thin sheet of neurons deep within the cortex, yet it reaches out to every other region of the brain.
Its true purpose remains “hidden away†as well, with researchers speculating about its functions. For example, Dr. Francis Crick, the British biologist and neuroscientist who proposed the double helix structure of the DNA molecule, believed that the claustrum was the seat of consciousness, responsible for awareness and sense of self.
What is known is that this region contains a large number of receptors targeted by psychedelic drugs such as LSD or psilocybin.
To see what happens in the claustrum when people are on psychedelics, the researchers compared the brain scans of people after they took psilocybin with their scans after taking a placebo.
The scans after psilocybin use showed that the claustrum was less active, meaning the area of the brain believed responsible for setting attention and switching tasks is turned down when on the drug.
The researchers say that this ties in with what people report as typical effects of psychedelic drugs, including feelings of being connected to everything and reduced senses of self or ego.
“Our findings move us one step closer to understanding mechanisms underlying how psilocybin works in the brain,†says Frederick Barrett, Ph.D., assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine and a member of the school’s Center for Psychedelic and Consciousness Research.
“This will hopefully enable us to better understand why it’s an effective therapy for certain psychiatric disorders, which might help us tailor therapies to help people more.â€
Because of its deep-rooted location in the brain, the claustrum has been difficult to access and study. Last year, Barrett and his colleagues at the University of Maryland, Baltimore, developed a method to detect brain activity in the claustrum using functional magnetic resonance imaging (fMRI).
In this study, the researchers used fMRI with 15 people and observed the claustrum brain region after the participants took either psilocybin or a placebo. They found that psilocybin reduced neural activity in the claustrum by 15% to 30%.
This reduced activity also appeared to be linked to the stronger subjective effects of the drug, such as emotional and mystical experiences. The team also found that psilocybin changed the way that the claustrum communicated with brain regions involved in hearing, attention, decision-making and remembering.
With the highly detailed imaging of the claustrum provided by fMRI, the researchers hope to look at this mysterious brain region in people with certain psychiatric disorders such as depression and substance use disorder.
The aim of this research would be to see what roles, if any, the claustrum plays in these conditions. The team also plans to observe the claustrum’s activity when under the influence of other psychedelics, such as salvinorin A, a hallucinogen derived from a Mexican plant.
The findings are published online in the journal NeuroImage.
Posted by AGORACOM-JC
at 9:07 AM on Thursday, June 11th, 2020
Announcd the appointment of Dr. Jason Dyck and the appointment of Dr. Sandra Stoddard to the company’s Scientific Advisory Board
TORONTO, ON and NEW YORK, NY / June 11, 2020 /Eyecarrot Innovations Corp (TSXV:EYC)(QTCQB:EYCCF)(2EYA:GR) is pleased to announce the appointment of Dr. Jason Dyck and the appointment of Dr. Sandra Stoddard to the company’s Scientific Advisory Board.
About Dr. Jason Dyck
Dr. Jason Dyck is a world-class research scientist and professor in the Department of Pediatrics at the University of Alberta, the director of the University of Alberta Cardiovascular Research Centre, a Canada Research Chair in Molecular Medicine, and a fellow of the Canadian Academy of Health Sciences. Dr. Dyck also has a wealth of experience in establishing and directing large interdisciplinary research teams, which provides the strongest foundation for credible and useful research to reach key stakeholders and improve healthcare and health outcomes.
Dr. Dyck has published over 220 peer-reviewed papers and is a recognized expert in basic biomedical research, which has attracted international recognition and has contributed to him being invited to co-chair the National Research Council for Diabetes Canada, and to serve on the Editorial boards of 4 major international journals. Dr. Dyck also reviews grants for international granting bodies such as The National Aeronautics and Space Administration (NASA), the National Institute for Health (NIH), the Welcome Trust, the National Health and Medical Research Council of Australia, the Dutch Diabetes Research Foundation and the European Research Council. Dr. Dyck was recognized as one of Canada’s Top 40 under 40 (awarded by the Caldwell Partners).
“I’m excited by this opportunity to learn from the Eyecarrot team and to assist the science advance to the clinical testing phase for both educational purposes and sports medicine applications. I am impressed with the passion that Adam brings to this company and with this new team that he has assembled. Working alongside Mr. Booth again in this capacity is important because he has the passion, vision and experience to help this company achieve its goals,” stated Dr. Jason Dyck PhD, Eyecarrot Scientific Advisory Board.
“Dr. Dyck has a track record of excellence at all levels, and his background in research, leadership, and business development are key attributes that will help drive the scientific backing and product offerings included in the Binovi Platform,” commented Adam Cegielski, Eyecarrot CEO.
“As Chief Scientific Officer, I welcome the scientific perspectives of accomplished researchers such as Dr. Dyck”, added Dr. Leonard Press, newly appointed Eyecarrot CSO.
About Dr. Sandra Stoddard
Dr. Sandra Stoddard is a distinguished educator who has devoted her entire 32-year career to ensuring her personal vision: success for all students. For Dr. Stoddard, this is not just a statement, but a passion. She holds a Bachelors of Education, a Masters in Educational Psychology in the area of Mild and Moderate Disabilities and a PhD in Educational Psychology. She was the recipient of the Nadene M. Thomas Graduate Research Bursary for her PhD Dissertation: Predicting First-Year Teaching Proficiency.
Throughout her career, Dr. Stoddard has served in many capacities including teacher, educational consultant, assistant principal, principal, director and executive director. She is currently the Associate Superintendent of a public-school division and oversees Early Learning, Inclusive Learning, Curriculum and Instructional Supports, Information Technologies, as well as all the Elementary schools within the Division. Outside of the Educational arena, Dr. Stoddard served as the Senior Manager of the Innovation and Improvement Unit, Research and Innovation Branch, within the Government of Alberta. In this role, she established and led a unit responsible for a variety of initiatives that involved partnerships with other Ministries, community agencies, private sector organizations, provincial associations, and academic institutions, all with the aim of engaging communities and individuals to improve support and services to Alberta’s vulnerable children, youth, and families. During this role, she was a recipient of the Premier’s Award of Excellence.
At the international level, Dr. Stoddard served as a Board of Director for the Association for Supervision and Curriculum Development (ASCD), a global organization comprised of 115,000 members in more than 128 countries, working to pursue excellence in learning, teaching and leading. As a result of meeting with education and government officials in numerous countries, she is fully aware of issues in education that are international in scope which will enhance our ability to potentially contribute to positive educational outcomes on a global level.
“I am excited to be a part of Eyecarrot and integrating Binovi into practice. Preliminary research suggests that vision therapy can be used to improve reading fluency, reading comprehension and other educational outcomes. For far too long, education has been working in a silo to try to address educational challenges. The impact of integrating medical and educational research, to support success for all students, has the potential to be transformational,” stated Dr. Sandra Stoddard B.Ed, M.Ed, PhD, Eyecarrot Scientific Advisory Board.
“Dr. Stoddard’s wealth of experience in integrating educational theory into practice will be an asset to the company as we collaborate, to improve educational outcomes for students,” commented Eyecarrot CEO Adam Cegielski.
“Vision is an integral component of learning, and I look forward to working with Dr. Stoddard on optimizing the transfer of visual abilities to the educational environment”, noted Dr. Leonard Press, Chief Scientific Officer of Eyecarrot.
In addition to the affirmation of Dr. Dyck and Dr. Stoddard to the Scientific Advisory Board, Mr. Terry Booth, Founder and former CEO of Aurora Cannabis (ACB), was appointed as the Company’s Executive Chairman. Mr. Booth skillfully raised Aurora from its infancy into one of the world’s largest and fastest growing cannabis companies, valued at $18B at its peak, with a focus on providing high-quality medical and adult usage cannabis and inspiring better days for medical and recreational consumers around the world. Mr. Booth is instrumental in coordinating the contributions of Dr. Jason Dyck and Dr. Sandra Stoddard to the expansion of Eyecarrot’s Binovi Platform.
The company is driven to leveraging expert knowledge as part of the development, expansion, and delivery of the Binovi Platform to clients in all industries, from education, to sports, to optometry, and beyond.
Eyecarrot is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.
Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com. The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 8:41 AM on Thursday, June 11th, 2020
HPQ has signed a non-disclosure agreement with an advanced materials developer for the purposes of exchanging technical information and sending silicon samples produced by the PUREVAP™Â Nano Silicon Reactor (NSIR) for energy storage applications testing
For industry competitive reasons, and according to the terms of the NDA, the identity of the advanced materials developer must remain confidential
MONTREAL, June 11, 2020 — HPQ Silicon Resources Inc. (“HPQâ€Â or the “Companyâ€) TSX-V: HPQ; FWB: UGE; Other OTC : URAGF; is pleased to announce that HPQ has signed a non-disclosure agreement (“NDAâ€) with an advanced materials developer for the purposes of exchanging technical information and sending silicon samples produced by the PUREVAP™Â Nano Silicon Reactor (NSIR) for energy storage applications testing. For industry competitive reasons, and according to the terms of the NDA, the identity of the advanced materials developer must remain confidential.
“This NDA is further indications that the game changing potential of the PUREVAP™ NSiR process we are developing with PyroGenesis Canada Inc. (TSX-V: PYR) is attracting interest from participants involved in the energy storage race. Being able to start technical discussions before producing samples is an incredible advantage, as it allows us to better match our material characteristics with what market participants are looking for,†said Bernard Tourillon, President and CEO HPQ Silicon. “Silicon’s potential to meet energy storage demand is undeniable and generating massive investments, and serious industry interest, so our timing could not be better. Suffice it to say, we are very pleased to continue attracting such early interest. However, I must caution investors that although this agreement does signal the interest in our unique products, we are still at the very preliminary stages and there is no guarantee that anything of commercial value will materialize from these efforts. It does however demonstrate the potential for new and exciting advances by HPQ in the silicon energy space.â€
GAME CHANGING POTENTIAL OF OUR PUREVAP™ NANO SILICON (Si) REACTOR GETTING NOTICED
Nano Silicon (Si) Powders have been identified as the key element that will allow the manufacture of high-performance Li-ion batteries to deliver on the research promises of an almost tenfold (10x) increase in the specific capacity of the anode, inducing a 20-40% gain in the energy density of Li-ion batteries. The PUREVAP™ NSiR process is purposely being developed to address the fact that current manufacturing processes to make Nano Silicon (Si) Powders are not very scalable and simply too expensive to be commercially feasible, requiring up to US$ 30,000/kg1 selling prices to justify production.
GLOBAL ENERGY STORAGE MARKET READY TO EXPLODE
A recent report by Wood Mackenzie Power & Renewable’s Report projects that energy storage deployments are estimated to grow 1,300% from a 12 Gigawatt-hour market in 2018 to a 158 Gigawatt-hour market in 2024. Meanwhile, at current growth rates of 2% per year, global energy consumption will be an estimated 125,000 Terawatt-hours, which is 800,000 times more than the estimated storage capacity. An estimated US$71 billion in investments will be made into storage systems where batteries will make up the lion’s share of capital deployment
_______ 1 Source: Quotation from a producer (Confidential), Media article
About Silicon
Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RERâ€) presently under way. Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.
About HPQ Silicon
HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal, building a portfolio of unique high value specialty silicon products needed for the coming RER.
Working with PyroGenesis Canada Inc.(TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:
The PUREVAP™ “Quartz Reduction Reactors†(QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential; ° HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);
The PUREVAP™ Nano Silicon Reactor (NSiR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires; ° HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries; ° During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAP™SiNR.
HPQ is also working with industry leader Apollon Solar of France to:
Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders; ° The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid-state batteries and porous silicon powders for Li-ion batteries. ° The plan is to deliver porous Si wafer to a battery manufacturer (under NDA) for testing in 2020.
This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
Disclaimers:
The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information contact
Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011 Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239 http://www.hpqsilicon.com Email: [email protected]
Posted by AGORACOM-JC
at 7:18 AM on Thursday, June 11th, 2020
For the month of May 2020, Venom reports that it generated record revenue of CDN$ 3.75 million from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges, representing the highest revenue Venom has achieved in a single month
As compared to May 2019, Venom’s revenue increased 163%.Â
VANCOUVER, BC, June 11, 2020 -Â Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF)Â ( FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce that its 100% owned subsidiary Venom Extracts (“Venom“) generated record revenue and EBITDA for the month of May 2020.Â
For the month of May 2020, Venom reports that it generated record revenue of CDN$ 3.75 million from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges, representing the highest revenue Venom has achieved in a single month. As compared to May 2019, Venom’s revenue increased 163%. The Company cautions that revenue figures have not yet been audited and are based on reports prepared by Venom management.
“We are firing on all cylinders here at Venom” shared Jake Cohen, Founder of Venom Extracts. “Having our best month ever in terms of revenue and EBITDA speaks to the resilience of our business model in the face of these uncertain times as well as the healthy customer demand for our product line.”
“We are very excited to see these record monthly revenues. We are looking forward to replicating Venom’s business model in our California facilities and beyond.” shared Carl Saling, CEO of Hollister Biosciences Inc.
About Hollister Biosciences Inc.
Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.
The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.
Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com
Tags: Cannabis, CBD, CSE, Hemp, small cap, tsx Posted in Featured, Hollister Biosciences | Comments Off on Hollister Bioscience’s $HOLL.ca 100% Owned Subsidiary #Venom Extracts Generates Record Monthly Revenue of $3.75 million CDN in May 2020 $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca
Posted by AGORACOM-JC
at 2:38 PM on Wednesday, June 10th, 2020
Received purchase orders for COVID-19 test kits from a Canadian Health and Safety Company
PO is comprising of 2,000 1 Drop Inc.’s Nucleic Acid test kits, 2,000 Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes, 4 Real-Time PCR Detection System machines to analyze the samples, and 1 RNA extractor
The total value of the PO is approximately $360,000 CDN.
TORONTO, June 10, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has received purchase orders (the “PO”) for COVID-19 test kits from a Canadian Health and Safety Company.
The PO is comprising of 2,000 1 Drop Inc.’s Nucleic Acid test kits, 2,000 Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes, 4 Real-Time PCR Detection System machines to analyze the samples, and 1 RNA extractor.
Datametrex is ready to supply a strong demand in the North American market for clinically supported COVID-19 test kits. The total value of the PO is approximately $360,000 CDN.
Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits. The Company has secured all testing kits, swabs, tubes and the PCR machine from the manufacturer required to fulfill the order. All the items will be shipped directly from manufacturers to the purchasers at their operating site in British Columbia.
“According to Coherent Market Insights, the global COVID-19 detection kits market is estimated to be valued at US$ 3.30 billion in 2020. We are working diligently to support global efforts in reducing the spread of the virus. These tests are vital for management to help protect employees as they provide accurate diagnoses and enable the prevention of the spread of the infection,” says Marshall Gunter, CEO of the Company.
Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.
About Datametrex
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com
For further information, please contact:
Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may,” “will,” “expect,” “likely,” “should,” “would,” “plan,” “anticipate,” “intend,” “potential,” “proposed,” “estimate,” “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 11:08 AM on Wednesday, June 10th, 2020
As the name implies, ImagineAR (CSE: IP) (OTCQB: IPNFF) is an Augmented Reality Company that enables businesses to create their own mobile phone AR campaigns with no programming or technology experience. AR is essentially a technology that lays digital images and graphics over the real world.
Apple CEO Tim Cook “AR Will play an important role in how we use technology in the future – and promises to be as influential in our society as the smart phoneâ€
Already Started Commercializing Its Augmented Reality Platform
Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape, Basketball Hall of Fame
Microsoft Authorized Co-Sell Partner
ImagineAR is now well positioned to further commercialize and capitalize on massive demand for Augmented Reality
Signed 5 Year $US 300,000 Licensing Agreement With SlapIt On To Provide Augmented Reality For Athletes and Celebrities To Engage Fans
Announced Partnership with Engaged Nation, An Award Winning Leader In Digital Engagement Marketing For Casinos
A top ranked global consulting firm with over 5,000 consultants and 70 offices around the world.
Ranked on the Forbes 2020 America’s Best Management Consulting Firms list, placing in seven categories, including one of only 31 firms ranked for Internet, Media and Entertainment.
Tags: AR, augmented reality, CSE, small cap, stocks, tsx, tsx-v Posted in AGORACOM Via Satellite, Imagine AR | Comments Off on INTERVIEW: Imagine #AR $IP.ca Discusses Partnership with North Highland, Ranked By #Forbes As One Of America’s Best Management Consulting Firms In 2020 $SEV.ca $VST.ca $YDX.ca $NTAR.ca
Posted by AGORACOM-JC
at 9:33 AM on Wednesday, June 10th, 2020
Former executive from LOTTE Data Communication Ltd., Edward Choi, joined the Company to head up the sales team in Seoul, South Korea
Edward was a Vice President at LOTTE for leading Lotte’s cyber security division
TORONTO, June 10, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that former executive from LOTTE Data Communication Ltd. (“LOTTEâ€), Edward Choi, joined the Company to head up the sales team in Seoul, South Korea. Edward was a Vice President at LOTTE for leading Lotte’s cyber security division.
“Adding Edward to the sales team in a leadership capacity is a strategic move for Datametrex. His contacts at LOTTE will allow Datametrex to open more doors and build on the strong foundation we’ve established these past three years,†says Marshall Gunter, CEO of the Company.
About Datametrex AI Limited
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact:
Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 8:48 AM on Wednesday, June 10th, 2020
KABN North America is a Canadian FinTech company that specializes in continuous online identity verification, management and monetization and is currently in development to launch a digital banking and financial services platform
KABN North America generates revenue by providing users, at no cost, with high value services and delivering permission-based offers that fit their aggregated public data profiles
Toronto, Ontario–(June 10, 2020) – KABN Systems NA Holdings Corp. (formerly Torino Power Solutions Inc.) (CSE: KABN) (the “Company” or “KABN” or “KABN North America“) is pleased to announce that it has commenced trading on the Canadian Securities Exchange under the symbol KABN as of today.
KABN North America is a Canadian FinTech company that specializes in continuous online identity verification, management and monetization and is currently in development to launch a digital banking and financial services platform. With the evolving macroenvironment and the increasing amount of time spent online, the Company believes that digital identity will become more important as users look to work, play, educate, game and shop virtually and will need to protect, manage and control the use of their digital identity.
KABN believes that ownership of identity is a basic human right and individuals should be the primary beneficiary of any use of their identity. The KABN North America platform provides, at no cost to consumers, the ability to create a digital identity with our Liquid Avatar platform (www.liquidavatar.com), verify their identity through KABN ID and create value for the use of their identity through KABN North America’s cashback, engagement and loyalty program, KABN KASH, as well as the KABN Visa card.
KABN North America generates revenue by providing our users, at no cost, with high value services and delivering permission-based offers that fit their aggregated public data profiles. KABN never rents, sells or provides data to outside parties without permission, and complies with jurisdictional privacy rules and regulations.
KABN North America Value Proposition
The Company is focused on 3 principle tenets that it believes will drive potential value:
The Addressable Market – Digital Identity is relevant to 100% of the online market.
The Unique Business Model – KABN’s solutions are built to empower users, generate revenue and create stakeholder value.
The Team – KABN’s management team, advisors and board of directors are seasoned executives from the technology, banking, payments and loyalty industry and have the acumen to help drive the Company to success.
KABN North America Product Suite
KABN North America has 4 primary products that enable users to verify, manage and monetize their digital identity:
KABN ID: a reusable, Always On, compliant, biometrically-based, identity verification and validation platform that forms the engine of the KABN Network.
LIQUID AVATAR: a digital image-based “wallet and keyring” platform that allows users to manage their digital identity.
KABN Card: an approved prepaid Visa card that includes a mobile banking wallet that supports both digital and traditional currencies.
KABN KASH: a robust loyalty and engagement platform with cashback and card-linked programs.
“We are excited to be trading on the CSE and we look forward to creating value for all of our stakeholders,” said Benjamin Kessler, CEO. “KABN North America is uniquely positioned to provide all our ecosystem partners with value given our low cost of user acquisition and our highly scalable infrastructure.”
Over the coming weeks, KABN will begin its rollout of products and programs, initially on an invitational basis only to its customers, social media, gaming and its network partners.
KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity. KABN propriety technology suite includes 4 key products:
KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.
Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allows users to use Liquid Avatars to share public and permission based private data when they want and with whom they want. www.liquidavatar.com
KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives.
KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.
KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs.
KABN Systems NA Holding Corp. is publicly traded on the Canadian Securities Exchange under the symbol: KABN
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.
By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.
Posted by AGORACOM
at 8:19 AM on Wednesday, June 10th, 2020
Revenue for the month of May totaled Cdn$5,141,000, representing an increase of 110% compared to May 2019
23,141 new customers during the month of May 2020
VANCOUVER, BC, CANADA / ACCESSWIRE / June 10, 2020 / Mota Ventures Corp. (CSE:MOTA) (FSE:1WZ1)(OTC PINK:PEMTF) (the “Company“) the Company’s subsidiary, Nature’s Exclusive, an eCommerce provider of CBD products to consumers in the United States, is pleased to announce an all-time monthly revenue record achieved during May 2020. Revenue for the month of May totaled Cdn$5,141,000, representing an increase of 110% compared to May 2019. Expenses totaled Cdn$4,992,000 for the month, representing a gross profit of Cdn$149,000 for May 2020.
The Company’s investment in customer acquisition continues to yield benefits with the brand acquiring 23,141 new customers during the month of May 2020. The Company’s strong ability to continue to acquire and retain new customers for its products continues to accelerate. As consumers continue to seek natural health product solutions, the Nature’s Exclusive brand is well positioned to offer consumers quality and convenience.
NATURE’S EXCLUSIVE CBD BRAND LEADING THE WAY
The Company’s Nature’s Exclusive brand offers a CBD hemp-oil formulation intended to provide users with the therapeutic benefits that hemp may offer. The hemp oil used in the products is derived from hemp grown and cultivated in the United States. The extraction process is designed to maintain all the beneficial qualities that hemp may offer. Nature’s Exclusive offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee.
“I am very pleased our Nature’s Exclusive brand achieved another monthly sales record. We continued to expand in the United States, and our outlook for the second half of fiscal 2020 is very positive. We remain on track to achieve our goals for 2020 despite the recent economic turmoil,” stated Ryan Hoggan, CEO of the Company.
We encourage readers to visit www.motaventuresco.com to view our brands and sign up to our newsletter.
The Company cautions that figures for revenue, expenses and margin generated from the sale of Nature’s Exclusive products in fiscal year 2020 have not been audited, and are based on calculations prepared by management. Actual results may differ from those reported in this release once these figures have been audited. These figures were translated from US dollars into Canadian dollars using the Bank of Canada monthly average exchange rate of US$1.00:Cdn$1.397 for May 2020 and US$1.00:Cdn$1.3459 for May 2019.
About Mota Ventures Corp.
Mota Ventures is an established eCommerce, direct to consumer provider of a wide range of natural health products including CBD and psychedelic medicine products in the United States and Europe. In the United States, the company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its Nature’s Exclusive brand. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. In Germany, Verrian currently produces natural psilocybin extract capsules under the PSI GEN and PSI GEN+ brand. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.
ON BEHALF OF THE BOARD OF DIRECTORS MOTA VENTURES CORP.
Ryan Hoggan Chief Executive Officer
For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.
